IGC Pharma, Inc.

Ownership Transactions Reported by 8 Insiders

Symbol
IGC on NYSE
Location
10224 Falls Road, Potomac, MD

There are no Buy or Sell transactions made by insiders since 9/18/2023

IGC Pharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Bradbury Strategic Investment Fund A (Cayman Islands Registration No. CR-359857) 10%+ Owner $4.7M Mar 22, 2024
Ram Mukunda CEO, Director $1.47M Mar 13, 2024
Richard K. Prins Director $355K Aug 12, 2024
Claudia Grimaldi Director $353K Mar 13, 2024
James P. Moran Director $120K Mar 13, 2024
Rohit Goel Senior Director of Finance&PAO $79.9K May 13, 2021
John E. LYNCH Director $45.7K May 31, 2022
Terry L. Lierman Director $10K Mar 13, 2024

Recent Insider Transactions by Companies or Individuals for IGC Pharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.